A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report

Author(s):
Verschoor, A.J. (0000-0001-9972-4241); Warmerdam, F.A.R.M.; Bosse, T.; Bovee, J.V.M.G. (0000-0003-1155-0481); Gelderblom, H.
Published
2018
Publication type
Article / Letter to editor
PazopanibEndometrial stromal sarcomaLiver functionAdverse eventsResponse
Date issued
2018-01-22
Language
English
Is part of
BMC Cancer
hdl
1887/76458
doi
10.1186/s12885-018-3999-0